Yannick Delpu, Ph.D.

Find him/her on :

Specialization

Yannick is a senior business development and go-to-market leader with 15+ years of experience at the interface of translational sciences and diagnostics. He drove the adoption of advanced genomics technologies from early validation to routine clinical and industrial use. He combines a strong scientific background with hands-on commercial execution to help biotech and diagnostics companies scale in complex European markets.

Key expertise areas

Notable engagements

Former Senior Director of Global Business Development at Bionano, Yannick played a central role in transitioning Optical Genome Mapping (OGM) from research into clinical diagnostics across EMEA and globally. His market access and commercialization strategy contributed to a fivefold increase in the installed base, a fourfold increase in consumables usage, and revenue growth from $4M to $16M over three years.

Yannick has built and led international business development teams, structured and managed KOL networks as commercial and regulatory levers, and supported over 40 laboratory-developed tests (LDTs). He also spearheaded European reimbursement initiatives and contributed to the inclusion of novel genomics technologies into clinical guidelines.

Beyond clinical diagnostics he developed new growth opportunities in biopharma and cell & gene therapy, establishing strategic partnerships with leading pharmaceutical companies and CDMOs, opening new revenue streams.

Markets

Europe and North America.

Academic background

Yannick holds a Ph.D. in Cancer Biology and completed a postdoctoral fellowship at New York University.

Our team